Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 3
1(20.0%)
5Total
N/A(4)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials
NCT05283213Completed

Development of an Innovative Clinico-biological Score for the Early Detection of Acute Renal Failure Associated With Cardiac Surgery.

Role: collaborator

NCT07013123Phase 3Not Yet Recruiting

Potency of HDM Sublingual AIT Tablets in Assuring the Persistency of Asthma Control in HDM Allergic Patients With Severe Asthma, Treated With Tezepelumab

Role: collaborator

NCT03815110Completed

Preeclampsia Risk Assessment: Evaluation of Cut-offs to Improve Stratification

Role: collaborator

NCT03651635Completed

MR-proADM and CT-proET-1 During ICU Treatment

Role: collaborator

NCT02449850Not ApplicableActive Not Recruiting

Preventing Atopic Dermatitis and ALLergies in Children

Role: collaborator

NCT02390999Not ApplicableCompleted

Neurological Prognostication of Patients in Therapeutic Hypothermia After Cardiac Arrest

Role: collaborator

NCT01857947Not ApplicableCompleted

Prognosis Value of Pro-adrenomedullin in Acute Exacerbations of COPD in ER

Role: lead

NCT01858675Not ApplicableCompleted

Biomarkers Correlation With Volemia

Role: lead

NCT01374880Unknown

Diagnostic and Prognostic Value of New Biomarkers in Patients With Heart Disease

Role: collaborator

NCT01227317Completed

BIOmarkers of Dyspnea IN Emergency Room

Role: lead

All 10 trials loaded